Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.85
(
-0.23%
)
US TECH 100
25,870.80
(
-0.32%
)
Dow Jones
49,407.77
(
-0.08%
)
Brent Oil
91.83
(
-0.90%
)
Bitcoin
76,492.97
(
3.56%
)
News Focus
News Focus
Post# of 257430
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122879
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 123683

Wednesday, 08/17/2011 12:58:54 PM

Wednesday, August 17, 2011 12:58:54 PM

Post# of 257430
PLB.TO acquires DDS.TO for C$0.2857/sh in cash:

http://finance.yahoo.com/news/Labopharm-Inc-Enters-Into-iw-1757402947.html?x=0

This appears to be another case of trying to make an eagle out of two turkeys. I’ve previously commented on Labopharm’s pathetic drug portfolio (especially Oleptro), so I won’t repeat that info here. The buyout values DDS.TO (net of cash on hand) at about $15M and is a 68% premium to yesterday’s closing price.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today